Edward J. Fiorentino
Executive Chairman
About us
Uncovering and delivering the new cornerstones of care
TerSera’s one-of-a-kind approach combines clinical expertise with a patient-first mentality to deliver therapeutics that transform patients’ lives.
Learn more about our Compliance & Integrity.
Our approach
We follow the science to uncover and expand new possibilities for patients.
Our team is tenacious in our pursuit of unique therapeutic opportunities. We combine a science-led approach with a holistic view of how patients experience treatment to uncover therapeutics with untapped potential in disease areas where there are limited or no known treatment options. We amplify each product’s ability to address unmet need and make a meaningful difference in patients’ lives.
Our team
Our team has a proven track record in drug development, commercialization, patient support, and business development, delivering a unique portfolio of one-and-only therapeutics across a broad range of therapeutic areas.
- Executive Leadership
- Board of Directors
John C. Landgraf
Dean S. Mihas
Edward J. Fiorentino
Executive Chairman
Edward Donovan
Chief Executive Officer
Mark Tatro
Executive Vice President, Chief Financial Officer
Mark Booth
Executive Vice President, Chief Commercial Officer
Jennifer Lagunas
Executive Vice President, Chief Legal Officer and Secretary
Nancy Martin, MD, PharmD
Executive Vice President, Research & Development, Chief Medical Officer
Vicky Papoutsis
Executive Vice President, Chief Strategy Officer
Bryan Reiners
Executive Vice President, Chief Insights Officer
